The Feng Yang lab's research involves the investigation of the molecular mechanisms underlying therapy-resistance of prostate cancer, tumor microenvironment - prostate cancer interaction, and developing novel transgenic model for human prostate cancer.
The lab is currently funded by the Department of Defense Prostate Cancer Research Program, National Institute of Health / National Cancer Institute, and the Cancer Prevention & Research Institute of Texas.
Our lab is involved with the following projects. Read more about each on our projects webpage.
- MAPK4 in regulating key signaling pathways in human cancers
- Tumor microenvironment regulation of prostate cancer
- Development of a novel transgenic model for prostate cancer
- FGFR1 signaling in prostate cancer and breast cancer